MedTrace Logo

Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool

NCT06044584 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-01-20

No results posted yet for this study

Summary

The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional approaches to pain management face challenges like unspecific drug use and high healthcare costs, and they often leave patients dissatisfied. PAIn-sense aims at comprehensively understanding pain from both physical and emotional perspectives. To accomplish this, the study will employ advanced Artificial Intelligence (AI) techniques and wearable sensing technology. The study aims to monitor patients continuously, during both day and night activities, to gather a multidimensional set of data on their physiological, psychosocial, and pain conditions.

Conditions

  • Nociceptive Pain
  • Neuropathic Pain

Interventions

OTHER

No intervention

Observational study with no intervention - Monitoring

Sponsors & Collaborators

  • Balgrist University Hospital

    collaborator OTHER

  • ETH Zurich

    lead OTHER

Principal Investigators

  • Stanisa Raspopovic, PhD · ETH Zurich

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-29
Primary Completion
2028-12-15
Completion
2028-12-31

Countries

  • Italy
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06044584 on ClinicalTrials.gov